Literature DB >> 3014040

Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes.

J G Wilson, E E Murphy, W W Wong, L B Klickstein, J H Weis, D T Fearon.   

Abstract

A genetic basis for the regulation of the number of CR1 on E of different normal individuals was investigated by probing Southern blots of their genomic DNA with a 0.75-kb fragment of CR1 cDNA. Using Hind III, we observed a RFLP involving fragments of 7.4 kb and 6.9 kb that correlated with the number of CR1 on E. 32 individuals having only the 7.4-kb restriction fragment had a mean of 661 +/- 33 (SEM) CR1/E, 11 donors having both restriction fragments had a mean of 455 +/- 52 CR1/E, and 7 individuals having only the 6.9-kb fragment had a mean of 156 +/- 13 CR1/E, all means being significantly different (p less than 0.005). Cosegregation in a normal family of the Hind III restriction fragments with the S, F, and F' structural allotypes of CR1 confirmed that the regulatory element identified by these fragments is linked to the CR1 gene. Moreover, an analysis of the relative expression on E of these structural allotypes in association with either the 7.4-kb Hind III fragment or the 6.9-kb fragment showed that this regulatory element is cis-acting. In contrast, quantitation of CR1 of B lymphocytes and neutrophils revealed no differences in total CR1 expression between individuals homozygous for the 7.4-kb and 6.9-kb Hind III fragments. Thus, we have identified a genomic polymorphism that is linked to the CR1 gene and is associated with a cis-acting regulatory element for the expression of CR1 on E.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014040      PMCID: PMC2188187          DOI: 10.1084/jem.164.1.50

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  ENZYMATIC DIGESTION OF RABBIT GAMMA GLOBULIN AND ANTIBODY AND CHROMATOGRAPHY OF DIGESTION PRODUCTS.

Authors:  A NISONOFF
Journal:  Methods Med Res       Date:  1964

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 3.  Complement ligand-receptor interactions that mediate biological responses.

Authors:  D T Fearon; W W Wong
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

4.  Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.

Authors:  M Reynes; J P Aubert; J H Cohen; J Audouin; V Tricottet; J Diebold; M D Kazatchkine
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

5.  Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b.

Authors:  W W Wong; L B Klickstein; J A Smith; J H Weis; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  PMA induces the ligand-independent internalization of CR1 on human neutrophils.

Authors:  P S Changelian; R M Jack; L A Collins; D T Fearon
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.

Authors:  S H Yoon; D T Fearon
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele.

Authors:  T R Dykman; J A Hatch; M S Aqua; J P Atkinson
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  48 in total

1.  Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species.

Authors:  E V Ruggieri; P J Bugelski; J M Kaplan; D Everitt; J Lipani; D K Jorkasky; S C Boike; F DeClement; F D Moore; D J Herzyk
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

2.  Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

Authors:  A Hammond; W Ollier; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Allelic variants of complement genes associated with dense deposit disease.

Authors:  Maria Asuncion Abrera-Abeleda; Carla Nishimura; Kathy Frees; Michael Jones; Tara Maga; Louis M Katz; Yuzhou Zhang; Richard J H Smith
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

4.  CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.

Authors:  J A Mitchell; R B Sim; E Sim
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

5.  Quantitative variation of C4 variant proteins associated with many MHC haplotypes.

Authors:  L Truedsson; Z Awdeh; E J Yunis; S Mrose; B Moore; C A Alper
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.

Authors:  J Miyaike; Y Iwasaki; A Takahashi; H Shimomura; H Taniguchi; N Koide; K Matsuura; T Ogura; K Tobe; T Tsuji
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Diminished adherence and/or ingestion of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients with tuberculosis.

Authors:  J Zabaleta; M Arias; J R Maya; L F García
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Erythrocyte complement receptor type 1 in non-SLE rheumatic diseases.

Authors:  J H Yen; H W Liu; S F Lin; T P Chen
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.

Authors:  P Cornillet; P Gredy; J L Pennaforte; O Meyer; M D Kazatchkine; J H Cohen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

10.  Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?

Authors:  P E Ruuska; I Ikäheimo; S Silvennoinen-Kassinen; M L Käär; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.